Drugstone Technology notifies the implementation of the redemption of Drugstone Convertible Bonds and the suspension of trading matters.

Nanjing PharmaStone Technology Co., Ltd. issued an important notice regarding the redemption and imminent suspension of trading of Pharmastone convertible bonds. The final trading day for the "Pharmastone bonds" is September 12, 2025, and trading will cease after the market closes; the final conversion date is September 17, and any bonds not converted will be redeemed at 100.62 yuan per bond. Investors may face losses. From July 25, 2025, to August 14, 2025, the company's stock triggered conditional redemption clauses. The company issued 11.5 million "Pharmastone bonds" in 2022, with a current conversion price of 33.61 yuan per share. Investors are reminded to open trading board permissions for conversion and to pay attention to the deadline and related risks.